Research ArticleArticle
Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study
Caroline Heijl, Kerstin Westman, Peter Höglund and Aladdin J. Mohammad
The Journal of Rheumatology September 2019, jrheum.181438; DOI: https://doi.org/10.3899/jrheum.181438
Caroline Heijl
Department of Clinical Sciences Lund, Nephrology, Lund University; Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; Department of Clinical Sciences, Rheumatology, Lund University; Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. Supported by The Swedish Rheumatism Association (Reumatikerförbundet), The Swedish Society of Medicine, The King Gustaf V’s 80-year foundation, and Region Skåne (REGSKANE-280361). C. Heijl, MD, PhD, Specialist in Nephrology, Department of Clinical Sciences Lund, Nephrology, Lund University; K. Westman, MD, PhD, Senior Consultant Nephrologist, Department of Clinical Sciences Lund, Nephrology, Lund University; P. Höglund, MD, PhD, Professor, Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; A.J. Mohammad, MD, MPH, PhD, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Lund University, and Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, 221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication August 19, 2019.
Kerstin Westman
Department of Clinical Sciences Lund, Nephrology, Lund University; Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; Department of Clinical Sciences, Rheumatology, Lund University; Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. Supported by The Swedish Rheumatism Association (Reumatikerförbundet), The Swedish Society of Medicine, The King Gustaf V’s 80-year foundation, and Region Skåne (REGSKANE-280361). C. Heijl, MD, PhD, Specialist in Nephrology, Department of Clinical Sciences Lund, Nephrology, Lund University; K. Westman, MD, PhD, Senior Consultant Nephrologist, Department of Clinical Sciences Lund, Nephrology, Lund University; P. Höglund, MD, PhD, Professor, Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; A.J. Mohammad, MD, MPH, PhD, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Lund University, and Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, 221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication August 19, 2019.
Peter Höglund
Department of Clinical Sciences Lund, Nephrology, Lund University; Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; Department of Clinical Sciences, Rheumatology, Lund University; Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. Supported by The Swedish Rheumatism Association (Reumatikerförbundet), The Swedish Society of Medicine, The King Gustaf V’s 80-year foundation, and Region Skåne (REGSKANE-280361). C. Heijl, MD, PhD, Specialist in Nephrology, Department of Clinical Sciences Lund, Nephrology, Lund University; K. Westman, MD, PhD, Senior Consultant Nephrologist, Department of Clinical Sciences Lund, Nephrology, Lund University; P. Höglund, MD, PhD, Professor, Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; A.J. Mohammad, MD, MPH, PhD, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Lund University, and Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, 221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication August 19, 2019.
Aladdin J. Mohammad
Department of Clinical Sciences Lund, Nephrology, Lund University; Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; Department of Clinical Sciences, Rheumatology, Lund University; Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. Supported by The Swedish Rheumatism Association (Reumatikerförbundet), The Swedish Society of Medicine, The King Gustaf V’s 80-year foundation, and Region Skåne (REGSKANE-280361). C. Heijl, MD, PhD, Specialist in Nephrology, Department of Clinical Sciences Lund, Nephrology, Lund University; K. Westman, MD, PhD, Senior Consultant Nephrologist, Department of Clinical Sciences Lund, Nephrology, Lund University; P. Höglund, MD, PhD, Professor, Department of Laboratory Medicine, Clinical Chemistry and Pharmacology, Lund University; A.J. Mohammad, MD, MPH, PhD, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Lund University, and Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, 221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication August 19, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study
Caroline Heijl, Kerstin Westman, Peter Höglund, Aladdin J. Mohammad
The Journal of Rheumatology Sep 2019, jrheum.181438; DOI: 10.3899/jrheum.181438